Latest DEF 14A proxy statements

Paramount Gold Nevada Corp. announces its 2025 Annual General Meeting to address director elections, auditor ratification, executive compensation, and an amendment to its stock incentive plan.

Oil-Dri Corporation of America announces its 2025 Annual Meeting of Stockholders, highlighting strong fiscal year 2025 financial performance and proposing the election of nine directors and ratification of its independent auditor.

LightPath Technologies, Inc. announces its Annual Meeting of Stockholders to vote on director elections, executive compensation, and an increase in its stock incentive plan, alongside reporting continued net losses.

Astrotech Corporation announced its 2025 Annual Meeting of Stockholders to elect directors, ratify auditors, and address corporate governance matters, amidst increasing net losses.

Global Crossing Airlines Group Inc. announces its 2025 Annual Meeting of Stockholders to vote on director elections, reapproval of equity incentive plans, and auditor ratification.

Artificial Intelligence Technology Solutions Inc. has increased its authorized common stock by 4.5 billion shares to a total of 27.5 billion, approved by majority shareholder consent.

Clean Energy Technologies, Inc. informs shareholders of recent financing transactions totaling $651,500 through convertible notes and common stock, approved by majority stockholders to maintain NASDAQ listing.

Dynatronics Corporation has filed definitive additional proxy soliciting materials with the SEC.

Glucotrack, Inc. reminds shareholders to vote on an Equity Purchase Agreement with Sixth Borough Capital Fund at a Special Meeting on October 31, 2025.

Avidity Biosciences announces a definitive merger agreement with Novartis, spinning off its early-stage precision cardiology programs.

ENDRA Life Sciences Inc. has filed a definitive proxy statement with the SEC, outlining information required for an upcoming shareholder meeting.

STAAR Surgical Company announced the postponement of its Special Meeting for the Alcon merger vote to December 3, 2025, citing ongoing discussions.

Procaccianti Hotel REIT, Inc. will hold its 2025 Annual Meeting to re-elect directors and vote on an amendment to its advisory agreement that would remove deadlines for certain fees.

Predictive Oncology Inc. faces a "going concern" warning and seeks shareholder approval for significant equity issuance and an expanded incentive plan amidst substantial net losses and declining shareholder returns.

Pulse Biosciences, Inc. announced its 2025 Annual Meeting of Stockholders to be held virtually on December 9, 2025, to vote on director elections, auditor ratification, executive compensation, and other corporate matters.

Dynatronics Corporation announced its 2025 Annual Meeting of Shareholders to vote on director elections, auditor ratification, and executive compensation matters.

Integrated BioPharma, Inc. announces its 2025 Annual Meeting to address director election, executive compensation, and auditor ratification.

AST SpaceMobile, Inc. is holding a Special Meeting to approve an amended incentive award plan, increasing shares for equity awards and extending the plan's term.

ENDRA Life Sciences Inc. calls for its 2025 Annual Meeting to vote on proposals including a significant increase in authorized shares and officer liability limitations.

La Rosa Holdings Corp. announced its 2025 Annual Meeting of Stockholders will be held virtually on December 11, 2025, to vote on director elections, auditor ratification, and an amendment to its equity incentive plan.

Tamboran Resources schedules its 2025 Annual Meeting to vote on director elections, auditor ratification, and equity incentive plan approvals.

Pulse Biosciences, Inc. has filed definitive additional proxy soliciting materials with the SEC.

Hycroft Mining Holding Corporation announces its 2025 Annual Meeting of Stockholders to vote on director elections, a new performance and incentive pay plan, and auditor ratification.

Activist investor Carronade Capital is soliciting proxies to elect four independent directors to Cannae Holdings' board, citing prolonged share price underperformance, poor governance, and misaligned management compensation.

Tesla's Board Chair Robyn Denholm calls on shareholders to approve Elon Musk's performance-based compensation and re-elect directors, emphasizing his critical role in the company's AI-driven future.

374Water Inc. is seeking shareholder approval for a reverse stock split to ensure its Nasdaq listing and attract a broader investor base.

Sotherly Hotels Inc. announced the deferral and indefinite suspension of preferred stock dividends, citing a board decision on October 27, 2025.

Cracker Barrel responds to a shareholder regarding its strategic plan, logo changes, and store remodels, emphasizing positive financial results and addressing public backlash.

The ODP Corporation's board unanimously recommends stockholders approve a $28.00 per share all-cash merger with ACR Ocean Resources LLC, representing a 34.5% premium.

Novartis AG will acquire Avidity Biosciences' neuroscience programs and RNA-targeting platform, while Avidity's early-stage precision cardiology programs will be spun off into a new public company, SpinCo.